logo
PFE_building
Bourla said he’s feeling well although experiencing very mild symptoms. He has received four doses of the COVID-19 vaccine, also made by Pfizer in collaboration with BioNTech SE

Pfizer CEO Albert Bourla tests COVID-19 positive with mild symptoms

Pfizer Inc (NYSE: PFE) Chief Executive Albert Bourla on Monday said he tested positive for COVID-19 and is receiving Paxlovid, the oral antiviral treatment made by his company

By Arghyadeep Dutta
Published - Aug 15, 2022, 10:28 AM ET
Last Updated - Jun 10, 2024, 06:42 AM EDT

Pfizer
Inc (NYSE:
PFE) Chief Executive Albert Bourla on Monday said he tested positive for COVID-19 and is receiving Paxlovid, the oral antiviral
treatment made by his company.

Bourla
said he’s feeling well although experiencing very mild symptoms. He has
received four doses of the COVID-19 vaccine, also made by Pfizer in
collaboration with BioNTech SE.

The
CEO is one of many people who have contracted coronavirus despite
receiving full vaccination and booster doses. The mutating coronavirus
has continually found ways to at least partially evade immunity induced
by shots and previous infections, although usually causing milder cases.

Bourla said he is “isolating in place as well as following all public health precautions.”

Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
4.2 12182024